Efficacy and tolerance of dupilumab in patients with moderate-to-severe atopic dermatitis and obesity

被引：0

作者：

Dupuis, Josephine ^{[1
]}

Tauber, Marie ^{[2
,3
]}

Mahe, Emmanuel ^{[4
]}

Jachiet, Marie ^{[5
]}

Soria, Angele ^{[6
]}

Tetart, Florence ^{[7
]}

Puzenat, Eve ^{[8
]}

Pasteur, Justine ^{[9
]}

Raison-Peyron, Nadia ^{[10
]}

Giordano-Labadie, Francoise ^{[11
]}

Droitcourt, Catherine ^{[12
]}

Leleu, Camille ^{[13
]}

Nosbaum, Audrey ^{[3
]}

Aubert, Helene ^{[14
]}

Moigne, Marie L. E. ^{[14
]}

Bernier, Claire ^{[14
]}

Barbarot, Sebastien ^{[15
]}

Ezzedine, Khaled ^{[16
]}

Diaz, Emmanuelle ^{[16
]}

Hubiche, Thomas ^{[17
]}

Faiz, Sarah ^{[18
]}

Azib, Selma ^{[1
]}

Dezoteux, Frederic ^{[1
,19
]}

Chosidow, Olivier ^{[20
]}

Staumont-Salle, Delphine ^{[1
,19
]}

机构：

[1] CHU Lille, Serv Dermatol, F-59037 Lille, France

[2] CHU Toulouse, Hop Larrey, Serv Dermatol, Toulouse, France

[3] Hop Lyon Sud, Allergol & Immunol Clin, CIRI Inserm U1111, Lyon, France

[4] Hop Victor Dupouy, Serv Dermatol, Argenteuil, France

[5] Hop St Louis, Dermatol, AP HP, Paris, France

[6] Hop Tenon, AP HP, Dermatol & Allergol, Paris, France

[7] CHU Rouen, Dermatol, Rouen, France

[8] CHU Besancon, Dermatol, Besancon, France

[9] CHU Clermont Ferrand, Dermatol, Clermont Ferrand, France

[10] CHU Montpellier, Dermatol, Montpellier, France

[11] CHU Toulouse, Dermatol, Toulouse, France

[12] Univ Rennes, Irset Inst Rech Sante, Dept Dermatol, CHU Rennes,Inserm,EHESP,UMR S 1085, Rennes, France

[13] Hop Bocage, Dermatol, Dijon, France

[14] CHU Nantes, Dermatol, Nantes, France

[15] Nantes Univ, Dept Dermatol, CHU Nantes, INRAE,UMR 1280,PhAN, Nantes, France

[16] Hop Henri Mondor, AP HP, Dermatol, Creteil, France

[17] Hop Archet 2, Dermatol, Nice, France

[18] CH Douai, Dermatol, Douai, France

[19] Univ Lille, Lille Inflammat Translat Res Inst INFINITE, INSERM U1286, Lille, France

[20] Univ Hosp La Pitie Salpetriere, AP HP, Facial Dermatosis Clin, Paris, France

来源：

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2024年

关键词：

D O I：

10.1111/jdv.20264

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页数：5

共 50 条

[21] Switching from dupilumab to abrocitinib in patients with moderate-to-severe atopic dermatitis: an analysis of responders and nonresponders to dupilumab
Silverberg, Jonathan, I
Simpson, Eric L.
Thyssen, Jacob P.
Pink, Andrew E.
Weidinger, Stephan
Chan, Gary
Lazariciu, Irina
Clibborn, Claire
Guler, Erman
[J]. BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
[22] Biomarkers in tear fluid of dupilumab-treated moderate-to-severe atopic dermatitis patients
Achten, Roselie
Thijs, Judith
van Luijk, Chantal
Knol, Edward
Delemarre, Eveline
de Graaf, Marlies
Bakker, Daphne
de Boer, Joke
van Wijk, Femke
de Bruin-Weller, Marjolein
[J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2023, 53 (02): : 239 - 243
[23] Long-Term Safety and Efficacy of Open-Label Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis
Deleuran, Mette
Thaci, Diamant
Beck, Lisa A.
Forman, Seth
Soong, Weily
Hussain, Iftikhar
Bissonnette, Robert
Bouaziz, Jean-David
Gelfand, Joel
Sher, Lawrence
Chen, Zhen
Akinlade, Bolanle
Gadkari, Abhijit
Eckert, Laurent
Graham, Neil M. H.
Pirozzi, Gianluca
Ardeleanu, Marius
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB381 - AB381
[24] Long-term safety and efficacy of open-label dupilumab in patients with moderate-to-severe atopic dermatitis
Deleuran, M.
Thaci, D.
Beck, L.
Forman, S.
Soong, W.
Hussain, I.
Bissonnette, R.
Bouaziz, J.
Gelfand, J.
Lawrence, S.
Chen, Z.
Akinlade, B.
Gadkari, A.
Eckert, L.
Graham, N.
Ardeleanu, M.
[J]. AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2019, 60 : 34 - 34
[25] Dupilumab Improves Skin Lipid Barrier in Pediatric Patients With Moderate-to-Severe Atopic Dermatitis
Bronova, Irina
Berdyshev, Evgeny
Goleva, Elena
Danby, Simon
Bronoff, Anna Sofia
Richers, Brittany
Garcia, Shannon
Gama, Marco Ramirez
Taylor, Patricia
Zahn, Joseph
Agueusop, Inoncent
Bafna, Shantanu
Boguniewicz, Mark
Ong, Peck
Zhang, Annie
Cork, Michael
Leung, Donald
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB5 - AB5
[26] Comparison of Efficacy of Baricitinib and Dupilumab in the Treatment of Chinese Moderate-To-Severe Atopic Dermatitis: A Retrospective Study
Liu, Bo
Song, Xiaoting
Liao, Shuanglu
Luan, Tingting
Zhao, Zuotao
[J]. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2023, 184 (10) : 966 - 974
[27] Economic Evaluation of Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults
Andreas Kuznik
Gaëlle Bégo-Le-Bagousse
Laurent Eckert
Abhijit Gadkari
Eric Simpson
Christopher N. Graham
LaStella Miles
Vera Mastey
Puneet Mahajan
Sean D. Sullivan
[J]. Dermatology and Therapy, 2017, 7 : 493 - 505
[28] Does Monthly Dupilumab Therapy Maintain its Clinical Efficacy in Moderate-to-Severe Atopic Dermatitis?
Kim, Su Min
Park, Chang Ook
[J]. ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2021, 13 (05) : 681 - 683
[29] Assessment of potential predictive factors of dupilumab response in patients with moderate-to-severe atopic dermatitis
Mele-Ninot, Gemma
Curto-Barredo, Laia
Bonfill-Orti, Montserrat
Exposito-Serrano, Vicente
Munera-Campos, Monica
Figueras Nart, Ignasi
Riquelme-Mc Loughlin, Constanza
Gomez-Armayones, Sara
Spertino, Jorge
Serra-Baldrich, Esther
[J]. AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2024, 65 (02) : 153 - 162
[30] A study into the drug dupilumab in Japanese adults with moderate-to-severe atopic dermatitis
不详
[J]. BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 (01) : E4 - E4

← 1 2 3 4 5 →